|
|
|
On this episode, ex-handballer Vladimir Cmiljanovic, Ph.D., Founder and CEO at Swiss Rockets, talks about co-discovering bimiralisib with his sister Natasa Cmiljanovic, Ph.D. (and COO at Swiss Rockets), losing his company to a hostile takeover, buying the company back, and building out Swiss Rockets as an incubator with manufacturing capabilities and shared scientific expertise. |
|
|
|
|
|
| Disclosure Management System: Build Or Buy? | Clinical trial disclosure regulations are tightening worldwide. In order to maintain compliance, sponsors must determine whether to build an internal disclosure management system or buy a solution. |
|
|
|
|
| What Treatment Options Do You Have For Me? | It’s the most important question from a patient-centric perspective. Examine the complexities surrounding patient access to treatment options, particularly in the context of clinical trials. |
|
|